{
  "docId": "019de077-4649-72e2-aa45-017392de211d",
  "docSlug": "8a7a8508ae9537047e1aabcda9819db4",
  "documentTitle": "NeuroSense Therapeutics | Investor Presentation Deck | 27 slides",
  "authorId": "neurosense-therapeutics",
  "authorName": "NeuroSense Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 27,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide uses a five-column icon-based layout to present key value propositions.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-4649-72e2-aa45-017392de211d/3",
  "deckHref": "/decks/019de077-4649-72e2-aa45-017392de211d",
  "deckJsonHref": "/decks/019de077-4649-72e2-aa45-017392de211d.json",
  "deckAnchorHref": "/decks/019de077-4649-72e2-aa45-017392de211d#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.19,
        "w": 0.87,
        "x": 0.065,
        "y": 0.265
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ee69388d-8574-42cf-a160-32b32e3e2223",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.175,
        "x": 0.228,
        "y": 0.475
      },
      "kind": "list",
      "text": "Significant results from placebo-controlled phase 2b study for ALS",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "265b9d6f-255b-4736-be56-dc6036e9ed9b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.175,
        "x": 0.048,
        "y": 0.475
      },
      "kind": "list",
      "text": "Developing novel therapies for neurodegenerative diseases of a high unmet need",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2f6a7d89-48f3-4583-b9a5-67420b5cc6ba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.175,
        "x": 0.413,
        "y": 0.475
      },
      "kind": "list",
      "text": "PrimeC slowed disease progression by 36.6% (p=0.009) over 12 months vs. patients initially on placebo",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c56aa3a-cde5-44c8-8517-abed257d2493",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.175,
        "x": 0.783,
        "y": 0.475
      },
      "kind": "list",
      "text": "Expedited and de-risked regulatory pathway; orphan drug designation / 505(b)2 pathway",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "84abb459-f991-4d40-9e9a-772bf165787d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.175,
        "x": 0.598,
        "y": 0.475
      },
      "kind": "list",
      "text": "Patent coverage for novel formulation, method & combination until 2042",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dc363ced-f2c1-49be-a7c1-6f4d79cbf799",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.075,
        "w": 0.428,
        "x": 0.076,
        "y": 0.115
      },
      "kind": "title",
      "text": "NeuroSense Highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77f5d59b-e30f-4974-97d1-938d08c7b90e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "e52a0cdc-b267-4d42-b20c-54146a9f6bb3",
      "evidence": "NeuroSense Highlights; list of key points",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "d435b502-6467-47c8-8efa-b470dd111de2",
      "evidence": "Five-column layout with icons and descriptive text",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}